サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：細胞株特性評価市場- 世界および地域別分析： 分析と予測（2024年～2033年）
市場調査レポート
商品コード
1397894

細胞株特性評価市場- 世界および地域別分析： 分析と予測（2024年～2033年）

Cell Line Characterization Market - A Global and Regional Analysis: Analysis and Forecast, 2024-2033
出版日: 受注後更新 | 発行: BIS Research | ページ情報: 英文 | 納期: 7～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
細胞株特性評価市場- 世界および地域別分析： 分析と予測（2024年～2033年）
出版日: 受注後更新
発行: BIS Research
ページ情報: 英文
納期: 7～10営業日
  • 全表示
  • 概要
  • 目次
概要

細胞株特性評価の市場規模は、バイオ医薬品に対する需要の増加、細胞ベースの研究の進歩、慢性疾患の有病率の上昇などを背景に、近年大きな成長を遂げています。

細胞株特性評価では、細胞株の同一性、純度、安定性、機能性を評価し、バイオ医薬品製品の再現性と安全性を確保します。

当レポートでは、世界の細胞株特性評価市場について調査し、市場の概要とともに、用途別、エンドユーザー別、細胞株タイプ別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

エグゼクティブサマリー

調査範囲

調査手法

第1章 世界の細胞株特性評価市場：市場概要

第2章 世界の細胞株特性評価市場：業界分析

  • 概要
  • 主要な動向
  • 規制分析

第3章 世界の細胞株特性評価市場：市場力学

  • 影響分析
  • 市場促進要因
  • 市場抑制要因
  • 市場機会

第4章 世界の細胞株特性評価市場、細胞株タイプ別、100万米ドル、2022年～2033年

  • 概要
  • 哺乳類
  • 微生物
  • 昆虫細胞

第5章 世界の細胞株特性評価市場、用途別、100万米ドル、2022年～2033年

  • 概要
  • 細胞株のアイデンティティ
  • 遺伝的安定性
  • ウイルスおよび微生物別汚染
  • その他

第6章 世界の細胞株特性評価市場、エンドユーザー別、100万米ドル、2022年～2033年

  • 概要
  • 製薬会社およびバイオテクノロジー企業
  • 学術研究機関
  • その他

第7章 世界の細胞株特性評価市場、地域別、100万米ドル、2022年～2033年

  • 概要
  • 北米の細胞株特性評価市場
  • 欧州の細胞株特性評価市場
  • アジア太平洋の細胞株特性評価市場
  • ラテンアメリカの細胞株特性評価市場
  • 中東・アフリカの細胞株特性評価市場

第8章 世界の細胞株特性評価市場：競合ベンチマーキングと企業プロファイル

  • 概要
  • 主要な戦略と展開
  • 企業プロファイル
    • Charles River Laboratories Merck KGaA Creative BioLabs Eurofins Scientific, Inc. Sartorius SGS S.A. GeneCopoeia Patho Quest Cell Line Genetics, Inc. Applied Genetics Laboratories, Inc. Creative Biogene
    • その他の企業
目次
Product Code: BHL1697SA

The Cell Line Characterization Market Report provides a comprehensive analysis of the global market, offering valuable insights into the current state, trends, and future prospects of the industry. Cell line characterization plays a pivotal role in the development and manufacturing of biopharmaceuticals, ensuring the reliability and consistency of cell-based products. This report explores key market drivers, challenges, emerging technologies, and competitive landscapes to assist stakeholders in making informed decisions.

The Cell Line Characterization Market has witnessed significant growth in recent years, driven by the increasing demand for biopharmaceuticals, advancements in cell-based research, and the rising prevalence of chronic diseases. Cell line characterization involves assessing the identity, purity, stability, and functionality of cell lines, ensuring the reproducibility and safety of biopharmaceutical products.

Market Segmentation:

Segmentation 1: by Application

  • Cell Line Identity
  • Genetic Stability
  • Viral and Microbial Contamination
  • Others

Segmentation 2: by End User

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Others

Segmentation 3: by Cell Line Type

  • Mammalian
  • Microbial
  • Insect Cell

Segmentation 4: by Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the Cell Line Characterization Market is characterized by the presence of key players adopting strategies such as mergers and acquisitions, collaborations, and product innovations. The report profiles leading companies, providing insights into their market share, product portfolio, and future growth strategies.

Some prominent players established in this market are:

  • Sartorius
  • Cell Line Genetics, Inc.
  • Applied Genetics Laboratories, Inc.

Key Questions Answered:

  • What are the major market drivers, challenges and opportunities in the global cell line characterization market?
  • How the cell line characterization market evolves and what did is its scope in the future?
  • How will each segment of the global cell line characterization market grow during the forecast period?
  • How will the industry evolve during the forecast period?
  • What are the key developmental strategies implemented by the key players to stand out in this market?

Table of Contents

Executive Summary

Scope of the Study

Research Methodology

1. Global Cell Line Characterization Market: Market Overview

  • 1.1. Product Definition
  • 1.2. Inclusion and Exclusion
  • 1.3. Key Findings

2. Global Cell Line Characterization Market: Industry Analysis

  • 2.1. Overview
  • 2.2. Key Trends
  • 2.3. Regulatory Analysis

3. Global Cell Line Characterization Market: Market Dynamics

  • 3.1. Impact Analysis
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Market Opportunities

4. Global Cell Line Characterization Market, by Cell Line Type, $Million, 2022-2033

  • 4.1. Overview
  • 4.2. Mammalian
  • 4.3. Microbial
  • 4.4. Insect Cell

5. Global Cell Line Characterization Market, by Application, $Million, 2022-2033

  • 5.1. Overview
  • 5.2. Cell Line Identity
  • 5.3. Genetic Stability
  • 5.4. Viral and Microbial Contamination
  • 5.5. Others

6. Global Cell Line Characterization Market, by End User, $Million, 2022-2033

  • 6.1. Overview
  • 6.2. Pharmaceutical and Biotechnology Companies
  • 6.3. Academic and Research Institutes
  • 6.4. Others

7. Global Cell Line Characterization Market, by Region, $Million, 2022-2033

  • 7.1. Overview
  • 7.2. North America Cell Line Characterization Market
    • 7.2.1. Market Dynamics
    • 7.2.2. Market Sizing and Forecast
      • 7.2.2.1. North America Cell Line Characterization Market, by Application
      • 7.2.2.2. North America Cell Line Characterization Market, by End User
      • 7.2.2.3. North America Cell Line Characterization Market, by Country
        • 7.2.2.3.1. U.S.
        • 7.2.2.3.2. Canada
  • 7.3. Europe Cell Line Characterization Market
    • 7.3.1. Market Dynamics
    • 7.3.2. Market Sizing and Forecast
      • 7.3.2.1. Europe Cell Line Characterization Market, by Application
      • 7.3.2.2. Europe Cell Line Characterization Market, by End User
      • 7.3.2.3. Europe Cell Line Characterization Market, by Country
        • 7.3.2.3.1. Germany
        • 7.3.2.3.2. U.K.
        • 7.3.2.3.3. Spain
        • 7.3.2.3.4. Italy
        • 7.3.2.3.5. France
        • 7.3.2.3.6. Rest-of-Europe
  • 7.4. Asia-Pacific Cell Line Characterization Market
    • 7.4.1. Market Dynamics
    • 7.4.2. Market Sizing and Forecast
      • 7.4.2.1. Asia-Pacific Cell Line Characterization Market, by Application
      • 7.4.2.2. Asia-Pacific Cell Line Characterization Market, by End User
      • 7.4.2.3. Asia-Pacific Cell Line Characterization Market, by Country
        • 7.4.2.3.1. China
        • 7.4.2.3.2. Japan
        • 7.4.2.3.3. India
        • 7.4.2.3.4. South Korea
        • 7.4.2.3.5. Rest-of-Asia-Pacific
  • 7.5. Latin America Cell Line Characterization Market
    • 7.5.1. Market Dynamics
    • 7.5.2. Market Sizing and Forecast
      • 7.5.2.1. Latin America Cell Line Characterization Market, by Application
      • 7.5.2.2. Latin America Cell Line Characterization Market, by End User
      • 7.5.2.3. Latin America Cell Line Characterization Market, by Country
        • 7.5.2.3.1. Brazil
        • 7.5.2.3.2. Mexico
        • 7.5.2.3.3. Rest-of-Latin America
  • 7.6. Middle East and Africa Cell Line Characterization Market
    • 7.6.1. Market Dynamics
    • 7.6.2. Market Sizing and Forecast
      • 7.6.2.1. Middle East and Africa Cell Line Characterization Market, by Product
      • 7.6.2.2. Middle East and Africa Cell Line Characterization Market, by End User

8. Global Cell Line Characterization Market: Competitive Benchmarking and Company Profiles

  • 8.1. Overview
  • 8.2. Key Strategies and Developments
    • 8.2.1. Partnership, Alliances, and Business Expansions
    • 8.2.2. Regulatory and Legal Activities
    • 8.2.3. New Offerings
    • 8.2.4. Mergers and Acquisitions
    • 8.2.5. Funding Activities
  • 8.3. Company Profiles
    • 8.3.1. Charles River Laboratories
      • 8.3.1.1. Company Overview
      • 8.3.1.2. Product Portfolio
      • 8.3.1.3. Key Competitors
      • 8.3.1.4. Target Customers
      • 8.3.1.5. Analyst Perspective
    • 8.3.2. Merck KGaA
    • 8.3.3. Creative BioLabs
    • 8.3.4. Eurofins Scientific, Inc.
    • 8.3.5. Sartorius
    • 8.3.6. SGS S.A.
    • 8.3.7. GeneCopoeia
    • 8.3.8. Patho Quest
    • 8.3.9. Cell Line Genetics, Inc.
    • 8.3.10. Applied Genetics Laboratories, Inc.
    • 8.3.11. Creative Biogene
    • 8.3.12. Other Companies